story of the week
Caffeine Blocks SREBP2-Induced Hepatic PCSK9 Expression to Enhance LDLR-Mediated Cholesterol Clearance
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Communications
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance
Nat Commun 2022 Feb 09;13(1)770, PF Lebeau, JH Byun, K Platko, P Saliba, M Sguazzin, ME MacDonald, G Paré, GR Steinberg, LJ Janssen, SA Igdoura, MA Tarnopolsky, SR Wayne Chen, NG Seidah, J Magolan, RC AustinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.